Publications

Publications from the Center Data Science Shared Resource in conjunction with Cancer Center members.

Published

  • Graff S, Subbiah I, Markham M, Matt-Amaral L, Close J, Griffith K, Jagsi R, Frequency, barriers, outcomes, and consequences of reporting sexual harassment in clinical oncology, JNCI Cancer Spectrum, 2023 Jan 3;7(1):pkac081, PMID: 36416149, PMCID: PMC9808769, doi: 10.1093/jncics/pkac081
  • Al-Holou W, Wang H, Rivikumar V, Shankar S, Oneka M, Fehmi Z, Verhaak R, Kim H, Pratt D, Camelo-Piragua S, Speers C, Wahl D, hollon T, Sagher O, Heth J, Muraszko K, Lawrence T, Carvalho A, Mikkelsen T, Rao A, Rehemtulla A, Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma, Neoplasia, 2023 Jan 6;36:100872, PMID: 36621024, PMCID: , doi: 10.1016/j.neo.2022.100872
  • Phung M, Webb P, DeFazio A, Fereday S, Lee A, Bowtell D, Fasching P, Goode E, Goodman M, Karlan B, Lester J, Matsuo K, Modugno F, Brenton J, Gorp T, Pharoah P, Schuldkraut J, McLean K, Meza R, Mukherjee B, Richarson J, Grout B, Chase A, Deurloo C, Terry K, Hanley G, Pike M, Berchuck A, Ramus S, Pearce C, Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery, Gynecol Oncol, 2023 Jan;168:68-75, PMID: 36401943, PMCID: , doi: 10.1016/j.ygyno.2022.10.018
  • Hawley S, Kidwell K, Zahrieh D, McCarthy A, Wills R, Rankin A, Hofer T, Chow S, Jagsi R, Neuman H, Improving patient-centered communication in breast cancer: a study protocol for a multilevel intervention of a shared treatment deliberation system (SharES) within the NCI community oncology research program (NCORP) (Alliance A231901CD), Trials, 2023 Jan 6;24(1):16., PMID: 36609349, PMCID: PMC9817354, doi: 10.1186/s13063-022-07048-4
  • Vince R, Jiang R, Bank M, Quarles J, Patel M, Sun Y, Hartman H, Zaorsky N, Jia A, Shoag J, Dess R, Mahal B, Stensland K, Eyrich N, Seymore M, Takele R, Morgan T, Schipper M, Spratt D, Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis, JAMA Network Open, 2023 Jan 3;6(1):e2250416, PMID: 36630135, PMCID: ,
  • Hammer L, Jiang R, Hearn J, Lashbrook J, Mitchell A, Daignault-Newton S, Dess R, Jackson W, Reichert Z, Alumkal J, Kaffenberger S, George A, Montgomery J, Salami S, Morgan T, Miller D, Wittman D, Hollenbeck, Mehra R, Davenport M, Sun Y, Schipper M, Palapattu G, Spratt D, A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer, Int J Radiat Oncol Biol Phys, 023 Jan 1;115(1):132-141, PMID: , PMCID: ,
  • Wages N, Braun T, Conaway M, Isotonic design for phase I cancer clinical trials with late-onset toxicities, J Biopharm Stat, 2023 Jan 6;1-14., PMID: 36606874, PMCID: , doi: 10.1080/10543406.2022.2162068

  • Stensland et al, Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy, JNCI Cancer Spectr, 2022 May 2;6(3):pkac025., PMID: 35616109, PMCID: PMC9134272, doi: 10.1093/jncics/pkac025
  • Vo J, Wu Y, Mishler J, Hall S, Mannan R, Waqng L, Ning Y Zhau J, Hopkins A, Estill J, Chan W, Yesel J, Cao X, Rao A, Tsodikov A, Talpaz M, Cole C Ye J, Auclair D, Cho H, Robinson D, Chinnaiyan, The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma, Nature Communications, 2022 Jun 29;13(1):3750, PMID: 35768438, PMCID: PMC9243087, doi: 10.1038/s41467-022-31430-0
  • Harper D, Plegue M, Jimbo M, Gorin S, Sen A, US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study, Elife, 2022 Jun 28;11:e76070, PMID: 35762572, PMCID: PMC9239676, doi: 10.7554/eLife.76070
  • Waljee A, Weinheimer-Hau E, Abubakar A, Ngugi A, Siwo G, Kwakye G, Singal A, Rao A, Saini S, Read A, Baker J, Balis U, Opio C, Zhu J, Saleh M, Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa, Gut, 2022 Jul;71(7):1259-1265, PMID: 35418482, PMCID: PMC9177787, doi: 10.1136/gutjnl-2022-327211
  • Krishnan S, Mohammed S, Frankel T, Rao A, GaWRDenMap: a quantitative framework to study the local variation in cell-cell interactions in pancreatic disease subtypes, Sci Rep, 2022 Mar 8;12(1):3708, PMID: 35260589, PMCID: PMC8904504, doi: 10.1038/s41598-022-06602-z
  • Najem et al, Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression, JCI Insight, 2022 May 9;7(9):e157612, PMID: 35316217, PMCID: PMC9090258, doi: 10.1172/jci.insight.157612
  • Abousamra et al, Deep Learning-Based Mapping of Tumor Infiltrating Lymphocytes in Whole Slide Images of 23 Types of Cancer, Front Oncol, 2022 Feb 16;11:806603, PMID: 35251953, PMCID: PMC8889499, doi: 10.3389/fonc.2021.806603
  • Masudo et al, Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy, JCO Precision Oncology, 2022 Mar;6:e2000368, PMID: 35294223, PMCID: PMC8939918, doi: 10.1200/PO.20.00368
  • Lee et al, Unsupervised machine learning for identifying important visual features through bag-of-words using histopathology data from chronic kidney disease, Sci Rep, 2022 Mar 22;12(1):4832, PMID: 35318420, PMCID: PMC8941143, doi: 10.1038/s41598-022-08974-8
  • Qin et al, Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer, Sci Rep, 2022 May 31;12(1):9054, PMID: 35641540, PMCID: PMC9156701, doi: 10.1038/s41598-022-13236-8
  • Pati et al, Federated learning enables big data for rare cancer boundary detection, Nature Communications, 2022 Dec 5;13(1):7346, PMID: 36470898, PMCID: PMC9722782, doi: 10.1038/s41467-022-33407-5
  • Haase et al, H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models, Journal of Clinical Investigation, 2022 Nov 15;132(22):e154229, PMID: 36125896, PMCID: PMC9663161, DOI: 10.1172/JCI154229
  • Mello et al, Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer, Oncogenesis, 2022 Sep 15;11(1):56, PMID: 36109493, PMCID: PMC9478137, DOI: 10.1038/s41389-022-00434-2
  • Griffith et al, MHC Class II Expression Influences the Composition and Distribution of Immune Cells in the Metastatic Colorectal Cancer Microenvironment, Cancer (Basel), 2022 Aug 24;14(17):4092, PMID: 36077630, PMCID: PMC9454847, doi: 10.3390/cancers14174092
  • Munoz et al, Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis, Scientific Reports, 2022 Aug 24;12(1):14449, PMID: 36002545, PMCID: PMC9402568, doi: 10.1038/s41598-022-15948-3
  • Warner et al, Investigating Useful Features for Overall Survival Prediction in Patients with Low-Grade Glioma Using Histology Slides, Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), , PMID: 36085890, PMCID: , DOI: 10.1109/EMBC48229.2022.9871027
  • Vo et al, The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma, Nature Communications, 2022 Jun 29;13(1):3750, PMID: 35768438, PMCID: PMC9243087, doi: 10.1038/s41467-022-31430-0
  • Velez-Delgado et al, Extrinsic KRAS Signaling Shapes the Pancreatic Microenvironment Through Fibroblast Reprogramming, Cell Mol Gastroenterol Hepatol, 2022;13(6):1673-1699, PMID: 35245687, PMCID: PMC9046274, doi: 10.1016/j.jcmgh.2022.02.016
  • Panigrahi et al, Integrative Bayesian models using Post-selective inference: A case study in radiogenomics, Biometrics, 44789, PMID: 35973786, PMCID: , DOI: 10.1111/biom.13740
  • Krishnan S, Barua S, Frankel T, Rao A, Towards the characterization of the tumor microenvironment through dictionary learning-based interpretable classification of multiplexed immunofluorescence images, Phys Med Biol, 2022 Dec 21;68(1), PMID: 36541756, PMCID: , doi: 10.1088/1361-6560/aca86a
  • Zhao Z, Fritsche L, Smith J, Bukherjee B, Lee S, The construction of cross-population polygenic risk scores using transfer learning, Am J Hum Genetics, 2022 Nov 3;109(11):1998-2008, PMID: 36240765, PMCID: PMC9674947, doi: 10.1016/j.ajhg.2022.09.010
  • Salvatore M, Purkayastha S, Ganapathi L, Bhattacharyya R, Kundu R, Zimmermann L, Ray D, Hazra A, Kleinsasser M, Solomon S, Subbaraman R, Mukherjee B, Lessons from SARS-CoV-2 in India: A data-driven framework for pandemic resilience, Sci Adv, 2022 Jun 17;8(24):eabp8621, PMID: 35714183, PMCID: PMC9205583, doi: 10.1126/sciadv.abp8621
  • Khoja et al, Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association, Gynocol Oncol, 2022 Jan;164(1):195-201, PMID: 34776242, PMCID: PMC9444325, doi: 10.1016/j.ygyno.2021.10.088
  • Chen et al, Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review, J Infect Dis, 2022 Apr 16;jiac136, PMID: 35429399, PMCID: PMC9047189, doi: 10.1093/infdis/jiac136
  • Du et al, Optimal diagnostic test allocation strategy during the COVID-19 pandemic and beyond, Stat Med , 2022 Jan 30;41(2):310-327, PMID: 34697824, PMCID: PMC8661762, doi: 10.1002/sim.9238
  • Brieger et al, High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival, Cancer Epidemiol Biomarkers Prev, 2022 Feb;31(2):443-452, PMID: 34789471, PMCID: PMC9281656, doi: 10.1158/1055-9965.EPI-21-0977
  • Beesley L, Mukherjee B, Statistical inference for association studies using electronic health records: handling both selection bias and outcome misclassification, Biometrics, 2022 Mar;78(1):214-226, PMID: 33179768, doi: 10.1111/biom.13400
  • Tsao et al, Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy, Oncologist, 2022 Apr 5;27(4):314-322, PMID: 35298660, PMCID: PMC8982372, doi: 10.1093/oncolo/oyab033
  • Apfelbaum A, Wu F, Wawkins A, Magnuson B, Jimenez J, Taylor S, Wrenn E, Waltner O, Pfaltzgraff E, Song J, Hall C, Wellik D, Ljungman M, Furlan S, Ryan R, Sarthy J, Lawlor E, EWS-FLI1 and HOXD13 control tumor cell plasticity in Ewing sarcoma, Clin Cancer Res, 2022 Jun 2;clincanres.0384.2022-2-5 13:20:00.280, PMID: 35653119, PMCID: PMC9588607, doi: 10.1158/1078-0432.CCR-22-0384
  • Wang et al, SurvMaximin: Robust federated approach to transporting survival risk prediction models, Journal of Biomedical Informatics, 2022 Oct;134:104176, PMID: 36007785, PMCID: PMC9707637, doi: 10.1016/j.jbi.2022.104176
  • , Surgical Management of Rhabdomyosarcoma of the Nasal Cavity and Paranasal Sinuses: Analysis of Operative Indications, Settings, and Outcomes, J Neurol Surg B Skull Base, , PMID: , PMCID: ,
  • Smith J, Bellile E, Ellsperman S, Heft-Neal M, Mann J, Birkeland A, Hoesli R, Swiecicki P, Worden F, Schonewolf C, Shah J, Mierzwa M, Rosko A, Stucken C, Chinn S, Shuman A, Casper K, Malloy K, Prince M, Wolf G, Thomas D, McHuhh J, Brenner J, SPector M, Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma, Oral Oncol, 2022 Dec;135:106226, PMID: 36323071, PMCID: , doi: 10.1016/j.oraloncology.2022.106226
  • Banerjee et al, Phosphorylation of TRIP13 at Y56 induces radiation resistance but sensitizes head and neck cancer to cetuximab, Mol Ther, 2022 Jan 5;30(1):468-484, PMID: 34111559, PMCID: PMC8753291 , doi: 10.1016/j.ymthe.2021.06.009
  • Costa de Medeiros M, Liu M, Banerjee R, Bellile E, D'Silva N, Rossa C, Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma, Cell Oncol (dordr), 2022 Apr;45(2):241-256, PMID: 35267186, PMCID: PMC9050779, doi: 10.1007/s13402-021-00631-y
  • Michmerhuizen et al, Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model, Oral Oncol, 2022 Mar;126:105770, PMID: 35172244, doi: 10.1016/j.oraloncology.2022.105770
  • Swiecicki et al, Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor, Head Neck,  2022 Jul;44(7):1509-1519, PMID: 35416374, doi: 10.1002/hed.27043
  • Rappold P, Vuong L, Leibold J, Chakiryan N, Curry M, Kuo F, Sabio E, Jiang H, Nixon B, Liu M, Berglund A, Silagy A, Mascareno E, Golkaram M, Marker M, Reising A, Savchenko A, Millholland J, Chen Y, Russo P, Coleman J, Reznik E, Manley B, Ostrovnaya I, Makarov V, DiNatale R, Blum K, Ma X, Chowell D, Li M, Solit D, Lowe S, Chan T, Motzer R, Voss M, Hakimi A, A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma, Cancer Discov, 2022 Jun 27;candisc.0925.2021, PMID: 35758895, doi: 10.1158/2159-8290
  • Wang M, Jiang H, Liu X, Wang X, Biophysics involved in the process of tumor immune escape, iScience, 2022 Mar 19;25(4):104124, PMID: 35402878, PMCID: PMC8983385, doi: 10.1016/j.isci.2022.104124
  • Jiang H, Huang L, Xia Y, Nonparametric regression with right-censored covariate via conditional density function, Stat Med , 2022 May 20;41(11):2025-2051, PMID: 35124839, doi: 10.1002/sim.9343
  • Wu W, Taylor JMG, Brouwer A, Luo L, Kang J, Jiang H, He K, Scalable proximal methods for cause-specific hazard modeling with time-varying coefficients, Lifetime Data Anal, 2022 Apr;28(2):194-218, PMID: 35092553, PMCID: PMC9201734, doi: 10.1007/s10985-021-09544-2
  • Schmitd L, Perez-Pacheco C, Bellile E, Wu W, Casper K, Mierza M, Rozek L, Wolf G, Taylor JMG, D'Silva N, Spatial and Transcriptomic Analysis of Perineural Invasion in Oral Cancer, Clin Cancer Res, 2022 May 26;clincanres.4543.2021, PMID: 35617517, PMCID: PMC9560986, doi: 10.1158/1078-0432.CCR-21-4543
  • Chang et al, Impact of Nodal Metastases in HPV-negative Oropharyngeal Cancer, Cancer Epidemiol Biomarkers Prev, 2022 May 17;cebp.0776.2021, PMID: 35579907, doi: 10.1158/1055-9965.EPI-21-0776
  • Getz et al, The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma, Head Neck, 2022 Jun;44(6):1393-1403, PMID: 35338544, PMCID: PMC9088158 , doi: 10.1002/hed.27040
  • Li P, Taylor JMG, Boonstra P, Lawrence T, Schipper M, Utility based approach in individualized optimal dose selection using machine learning methods, Stat Med , 2022 Jul 20;41(16):2957-2977, PMID: 35343595, PMCID: PMC9233043, doi: 10.1002/sim.9396.
  • Chua et al, Myotubularin-related phosphatase 5 is a critical determinant of autophagy in neurons, Curr Biol, 2022 Jun 20;32(12):2581-2595.e6, PMID: 35580604, PMCID: PMC9233098, doi: 10.1016/j.cub.2022.04.053
  • Yi et al, KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical Activin Pathway, Cell Mol Gastroenterol Hepatol, 2022;13(2):643-667, PMID: 34583087, PMCID: PMC8715196, doi: 10.1016/j.jcmgh.2021.09.014
  • Kidwell et al, Application of Bayesian methods to accelerate rare disease drug development: scopes and hurdles, Orphanet J Rare Dis, 2022 May 7;17(1):186, PMID: 35526036, PMCID: PMC9077995, doi: 10.1186/s13023-022-02342-5
  • Hwang M, Medley S, Shakeel F, Vanderwerff B, Zawistowski M, Kidwell K, Hertz D, Lack of association of CYP2B6 pharmacogenetics with cyclophosphamide toxicity in patients with cancer, Support Care Cancer, 2022 Sep;30(9):7355-7363, PMID: 35606478, doi: 10.1007/s00520-022-07118-y
  • Novice et al, Identifying Barriers and Facilitators to Scalp Cooling Therapy Through a National Survey of the Awareness, Practice Patterns, and Attitudes of Oncologists, JCO Oncol Pract, 2022 Feb;18(2):e225-e234, PMID: 34529505, doi: 10.1200/OP.21.00273
  • Kurlander et al, Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial, Implement Sci Commun, 2022 Jan 28;3(1):8, PMID: 35090577, PMCID: PMC8796614, doi: 10.1186/s43058-022-00256-8
  • Acs et al, Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study, Mod Pathol, 2022 Oct;35(10):1362-1369, PMID: 35729220, PMCID: PMC9514990, doi: 10.1038/s41379-022-01104-9
  • Pasternak et al, Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy, Transplant Cell Therapy, 2022 Jan;28(1):19.e1-19.e7, PMID: 34583027, doi: 10.1016/j.jtct.2021.09.011
  • Joyce et al, Association between nociplastic pain and premature endocrine therapy discontinuation in breast cancer patients, Breast Cancer Research and Treatment, 44878, PMID: 36371776, PMCID: , doi: 10.1007/s10549-022-06806-x
  • Hertz et al, Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms, Support Care Cancer, 2022 Oct;30(10):8059-8067, PMID: 35776183, PMCID: PMC9529953, doi: 10.1007/s00520-022-07243-8
  • Gonzalez et al, EZH2 T367 phosphorylation activates p38 signaling through lysine methylation to promote breast cancer progression, iScience, 2022 Aug 2;25(8):104827., PMID: 35992062, PMCID: PMC9389258, doi: 10.1016/j.isci.2022.104827.
  • Chao Y, Tran Q, Tsodikov A, Kidwell K, Joint modeling and multiple comparisons with the best of data from a SMART with survival outcomes, Biostatistics, 2022 Jan 13;23(1):294-313, PMID: 32659784, doi: 10.1093/biostatistics/kxaa025
  • Chao et al, Power prior models for estimating response rates in a small n, sequential, multiple assignment, randomized trial, Statistical Methods in Medical Research, 2022 Dec;31(12):2297-2309, PMID: 36082955, PMCID: , doi: 10.1177/09622802221122795
  • Drake C, Kalmbach D, Cheng P, Ahmedani B, Peterson E, Joseph C, Roth T, Kidwell K, Sagong C, Sleep to Reduce Incident Depression Effectively (STRIDE): study protocol for a randomized controlled trial comparing stepped-care cognitive-behavioral therapy for insomnia versus sleep education control to prevent major depression, Trials, 2022 Dec 1;23(1):967, PMID: 36457045, PMCID: PMC9713737,
  • Subbiah I, Markham M, Graff S, Matt-Amaral L, Close J, Griffith K, Jagsi R, Incidence, Nature, and Consequences of Oncologists' Experiences With Sexual Harassment, J Clin Oncol, 2022 Apr 10;40(11):1186-1195, PMID: 35089804, PMCID: PMC8987225, doi: 10.1200/JCO.21.02574.
  • Jagsi R, Griffith K, Vicini F, Boike T, Dominello M, Gustafson G, Hayman J, Moran J, Radawski J, Walker E, Pierce L, Identifying Patients Whose Symptoms Are Underrecognized During Treatment With Breast Radiotherapy, JAMA Oncology, 2022 Jun 1;8(6):887-894, PMID: 35446337, PMCID: PMC9026246 , doi: 10.1001/jamaoncol.2022.0114
  • Jagsi R, Griffith K, Moran J, Vicini F, Pierce L, In Reply to Ling and Beriwal, Int J Radiat Oncol Biol Phys, 2022 Mar 15;112(4):1064, PMID: 35190050, doi: 10.1016/j.ijrobp.2021.11.018
  • Singer K, Burns C, Griffith K, Opipari V, Martin D, Shellhaas R, Jagsi R, Gender Differences in Endowed Chairs in Pediatrics, J Pediatr, 2022 May 27;S0022-3476(22)00492-9, PMID: 35636563, doi: 10.1016/j.jpeds.2022.05.040
  • Jones et al, Patient Experiences, Trust, and Preferences for Health Data Sharing, JCO Oncol Pract, 2022 Mar;18(3):e339-e350, PMID: 34855514, PMCID: PMC8932496 , doi: 10.1200/OP.21.00491
  • Mody et al, Gender Differences in Work-Family Conflict Experiences of Faculty in Academic Medicine, J Gen Intern Med, 2022 Jan;37(1):280-282, PMID: 33469767, PMCID: PMC8739409 , doi: 10.1007/s11606-020-06559-7
  • Jia et al, Factors Associated With Endowed Chair Allocation in Medical Oncology in the United States, JNCI Cancer Spectr, 2022 May 2;6(3):pkac036, PMID: 35657340, PMCID: PMC9165554, doi: 10.1093/jncics/pkac036
  • Gharzai L, Griffith K, Beeler W, Burrows H, Hammoud M, Rodgers P, Sabel M, Caethers J, Jagsi R, Speaker Introductions at Grand Rounds: Differences in Formality of Address by Gender and Specialty, J Women's Health (Larchmont), 2022 Feb;31(2):202-209, PMID: 34197213, doi: 10.1089/jwh.2021.0031
  • McClelland S, Huang C, Griffith K, Shan M, Holliday E, Jagsi R, Zellars R, Composition of the Current Academic Radiation Oncology Workforce in Comprehensive Cancer Centers, JCO Oncol Pract, 2022 May;18(5):e740-e747, PMID: 34919411, doi: 10.1200/OP.21.00609
  • Jagsi et al, Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort, Int J Radiat Oncol Biol Phys, 2022 Mar 15;112(4):853-860, PMID: 34718094, PMCID: PMC9020566 , doi: 10.1016/j.ijrobp.2021.10.012
  • Jagsi et al, Comparative Effectiveness Analysis of 3D-Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy (IMRT) in a Prospective Multicenter Cohort of Patients With Breast Cancer, Int J Radiat Oncol Biol Phys, 2022 Mar 1;112(3):643-653, PMID: 34634437, doi: 10.1016/j.ijrobp.2021.09.053
  • Dilworth et al, The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality Consortium, Int J Radiat Oncol Biol Phys, 2022 Jun 1;113(2):266-277, PMID: 35157997, doi: 10.1016/j.ijrobp.2022.02.004
  • Jagsi R, Griffith K, Underrecognition of Symptoms During Breast Radiotherapy-Reply, JAMA Oncology, 2022 Oct 1;8(10):1510-1511, PMID: 35951335, PMCID: , doi: 10.1001/jamaoncol.2022.3245
  • Coffman L, Orellana T, Liu T, Frisbie L, Normolle D, Griffith K, uppal S, McLean K, Berger J, Boisen M, Courtney-Brooks M, Edwards R, Lesnock J, Mahdi H, Olawaiye A, Sukumvanich P, Taylor S, Buckanovich R, Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer, JCI Insight, 2022 Sep 22;7(18):e160573, PMID: 35972817, PMCID: PMC9675476, doi: 10.1172/jci.insight.160573
  • Champan C, Jagsi R, Griffith K, Moran J, Vicini F, Walker E, Dominello M, Abu-Isa E, Hayman J, Laucis A, Mietzel M, Pierce L, Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients, J Natl Cancer Inst, 2022 Dec 8;114(12):1646-1655, PMID: 35916737, PMCID: , doi: 10.1093/jnci/djac120
  • Sahai V, Griffith K, Beg M, Shaib W, Mahalingam D, Zhen D, Deming D, Zalupski M, A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01, Cancer, 2022 Oct 1;128(19):3523-3530, PMID: 35895381, PMCID: PMC9540241, doi: 10.1002/cncr.34394
  • King R, Schaefer J, Sahai V, Griffith K, Sood S, Retrospective Cohort Analysis of Aspirin Use and Venous Thromboembolism in Patients with Pancreatic Cancer and an Indwelling Central Venous Catheter, TH Open, 2022 Aug 4;6(3):e221-e229, PMID: 36046199, PMCID: PMC9352440, doi: 10.1055/s-0042-1747685
  • Shen C, Risk M, Schiopu E, Hayek S, Xie T, Holevinski L, Akin C, Freed G, Zhao L, Efficacy of COVID-19 vaccines in patients taking immunosuppressants, Ann Rheum Dis, 2022 Jun;81(6):875-880, PMID: 35197265, PMCID: PMC9422955, doi: 10.1136/annrheumdis-2021-222045
  • Zhou K, Xia Y, Yang M, Xiao W, Zhao L, Hu R, Shoaib K, Yan R, Dai K, Actin polymerization regulates glycoprotein Ibα shedding, Platelets, 2022 Apr 3;33(3):381-389, PMID: 33979555, doi: 10.1080/09537104.2021.1922882
  • Liu et al, Carbodiphosphorane-Stabilized Parent Dioxophosphorane: A Valuable Synthetic HO 2 P Source, J Am Chem Soc,  2022 Apr 27;144(16):7357-7365, PMID: 35436104, doi: 10.1021/jacs.2c00936
  • Dong T, Fan W, Tao Y, Wu R, Wang L, Zhao L, Liu L, Fan Z, Duodenal obstruction associated with a ruptured pancreaticoduodenal artery aneurysm, Rev Esp Enferm Dig, 2022 Jul;114(7):438-439, PMID: 35199535, doi: 10.17235/reed.2022.8727/2022
  • He et al, Prognostic Value of Histidine-Rich Glycoprotein for Community-Acquired Pneumonia, Dis Markers, 2022 Feb 1;2022:4713045, PMID: 35154511, PMCID: PMC8824745, doi: 10.1155/2022/4713045
  • Zhang et al, TRX2/Rab35 Interaction Impairs Exosome Secretion by Inducing Rab35 Degradation, Int J Mol Sci, 2022 Jun 12;23(12):6557, PMID: 35743001, PMCID: PMC9224307, doi: 10.3390/ijms23126557
  • Risk et al, Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant, Clin Infect Dis, 2022 Feb 7;ciac106, PMID: 35137006, PMCID: PMC9047165, doi: 10.1093/cid/ciac106
  • Chen et al, Detection of Barrett's neoplasia with a near-infrared fluorescent heterodimeric peptide, Endoscopy, 2022 Mar 17., PMID: 35299273, doi: 10.1055/a-1801-2406
  • Liu Y, Zhou S, Zhao L Gu X, Identification of Neuronal Cells in Sciatic Nerves of Adult Rats, Front Cell Neuroscience, 2022 Mar 25;16:816814, PMID: 35401123, PMCID: PMC8991689, doi: 10.3389/fncel.2022.816814. 
  • Xing et al, Characteristics of peripheral blood Gamma-glutamyl transferase in different liver diseases, Medicine (Baltimore), 2022 Jan 7;101(1):e28443, PMID: 35029891, PMCID: PMC8735790, doi: 10.1097/MD.0000000000028443
  • Song et al, Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer, Sci Rep, 2022 Apr 28;12(1):6946, PMID: 35484177, PMCID: PMC9050689, doi: 10.1038/s41598-022-10561-w
  • Wei et al, Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4, Br J Cancer, 2022 Apr;126(7):1037-1046, PMID: 34912075, PMCID: PMC8980085, doi: 10.1038/s41416-021-01651-z
  • Bryant et al, De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer, Eur J Cancer, 2022 Jun 12;171:55-63, PMID: 35704975, doi: 10.1016/j.ejca.2022.04.033
  • Han et al, BCAP31 is involved in modulating colorectal cancer cell proliferation via the Emerin/β-catenin axis, Exp Cell Res, 2022 Jun 15;418(1):113265, PMID: 35716785, doi: 10.1016/j.yexcr.2022.113265
  • Bao et al, Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A, Cell Death Dis, 2022 Feb 25;13(2):189, PMID: 35217647, PMCID: PMC8881465, doi: 10.1038/s41419-022-04642-x
  • Taylor A, Setia N, Alpert L, Zhao L, Lamps L, Hart J, Waxman I, Hissong E, Choi E, Shi J, Owens S, Westerhoff M, Measuring the Submucosal Depth of Invasion in Endoscopic Mucosal Resections for Barrett-associated Adenocarcinoma, Arch Pathol Lab Med, 2022 Nov 1;146(11):1338-1344, PMID: 35213893, PMCID: PMC9402809, doi: 10.5858/arpa.2021-0072-OA
  • Worlikar et al, Impact of Histotripsy on Development of Intrahepatic Metastases in a Rodent Liver Tumor Model, Cancers (Basel),  2022 Mar 22;14(7):1612, PMID: 35406383, PMCID:  PMC8996987, doi: 10.3390/cancers14071612
  • Bryant et al, Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer, Lung Cancer, 2022 Jan;163:35-41, PMID: 34896803, PMCID: PMC8770596 , doi: 10.1016/j.lungcan.2021.11.021
  • Zhang et al, Long Non-Coding LEF1-AS1 Sponge miR-5100 Regulates Apoptosis and Autophagy in Gastric Cancer Cells via the miR-5100/DEK/AMPK-mTOR Axis, Int J Mol Sci, 2022 Apr 26;23(9):4787, PMID: 35563178, PMCID: PMC9101949, doi: 10.3390/ijms23094787
  • Bryant et al, Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer, Int J Radiat Oncol Biol Phys, 2022 May 1;113(1):60-65., PMID: 35115216, PMCID: PMC9018488 , doi: 10.1016/j.ijrobp.2021.12.176
  • Deng et al, Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota, Nutrients, 2022 Feb 9;14(4):726, PMID: 35215376, PMCID: PMC8879943, doi: 10.3390/nu14040726
  • Taylor et al, Cribriform colon cancer: a morphological growth pattern associated with extramural venous invasion, nodal metastases and microsatellite stability, J Clin Pathol, 2022 Jul;75(7):483-487, PMID: 33782192, doi: 10.1136/jclinpath-2021-207485
  • Yousif et al, Quantitative Image Analysis as an Adjunct to Manual Scoring of ER, PgR, and HER2 in Invasive Breast Carcinoma, Am J Clin Pathol, 2022 Jun 7;157(6):899-907, PMID: 34875014, doi: 10.1093/ajcp/aqab206
  • Jiang C, Zhao L, Schuetze S, Chugh R, Giant Cell Tumor of Bone: Effect of Longer Dosing Intervals of Denosumab on Tumor Control and Bone-related Complications, Oncologist, 2022 Jul 5;27(7):595-599, PMID: 35589095, PMCID: PMC9256029, doi: 10.1093/oncolo/oyac066
  • Sankar et al, Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer, Cancers (Basel),  2022 Jan 26;14(3):614., PMID: 35158881, PMCID: PMC8833364, doi: 10.3390/cancers14030614
  • Deng et al, SND1 acts as a functional target of miR-330-5p involved in modulating the proliferation, apoptosis and invasion of colorectal cancer cells, Biochem Biophys Res Commun, 2022 Jul 30;615:116-122, PMID: 35609416, doi: 10.1016/j.bbrc.2022.05.045
  • Song et al, Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Pre, Front Genet, 2022 May 27;13:850200, PMID: 35711939, PMCID: PMC9197218, doi: 10.3389/fgene.2022.850200
  • Bryant A, Sankar K, Strohbehn G, Zhao L, Daniel V, Elliott D, Ramnath N, Green M, Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab, Int J Radiat Oncol Biol Phys, 2022 Apr 18;S0360-3016(22)00248-6, PMID: 35450753, PMCID: PMC9246927, doi: 10.1016/j.ijrobp.2022.03.015
  • Wages N, Braun T, Normolle D, Schipper M, Adaptive Phase 1 Design in Radiation Therapy Trials, Int J Radiat Oncol Biol Phys, 2022 Jul 1;113(3):493-499, PMID: 35777394, PMCID: PMC9260906, doi: 10.1016/j.ijrobp.2022.02.031
  • Jackson W, Tang M, Schipper M, Sandler H, Zumsteg Z, Efstathiou J, Shipley W, Seiferheld W, Lukka H, Bahary JP, Zietman A, Pisansky T, Zeitzer K, Hall W, Dess R, Lovett R, Balogh A, Feng F, Spratt D, Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601, J Clin Oncol, 2022 Jun 23;JCO2102741, PMID: 35737923, PMCID: PMC9514834, doi: 10.1200/JCO.21.02741
  • Homer V, Yap C, Bond S, Holmes J, Stocken D, Walker K, Robinson E, Wheeler G, Brown S, Hinsley S, Schipper M, Weir C, Rantell K, Prior T, Yu L, Kirkpatrick J, Bedding A, Gamble C, Gaunt P, Early phase clinical trials extension to guidelines for the content of statistical analysis plans, BMJ, 2022 Feb 7;376:e068177, PMID: 35131744, PMCID: PMC8819597, doi: 10.1136/bmj-2021-068177
  • Cousins et al, Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After 90 Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity, J Nucl Medicine, 2022 Jun;63(6):882-889, PMID: 34503962, PMCID: PMC9157720, doi: 10.2967/jnumed.121.262447
  • Chase E, Bryant A, Sun Y, Jackson W, Spratt D, Dess R, Schipper M, Development and validation of a life expectancy calculator for US patients with prostate cancer, BJU Int, 2022 Oct;130(4):496-506, PMID: 35373440, PMCID: PMC9474626, doi: 10.1111/bju.15740
  • Bryant et al, Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer, Am J Clin Onc, 2022 Apr 1;45(4):142-145, PMID: 35271524, doi: 10.1097/COC.0000000000000899
  • Laucis et al, Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy, JCO Oncol Pract, 2022 Jun;18(6):e1034-e1044, PMID: 35167337, doi: 10.1200/OP.21.00224
  • Speers et al, Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase 2 Clinical Trial, Int J Radiat Oncol Biol Phys, 2022 Feb 1;112(2):417-425, PMID: 34509552, doi: 10.1016/j.ijrobp.2021.08.039
  • Wilkie et al, Association Between Physician- and Patient-Reported Symptoms in Patients Treated With Definitive Radiation Therapy for Locally Advanced Lung Cancer in a Statewide Consortium, Int J Radiat Oncol Biol Phys,  2022 Mar 15;112(4):942-950, PMID: 34838865, doi: 10.1016/j.ijrobp.2021.11.024
  • Owen et al, Investigating the Incidence of Pulmonary Abnormalities as Identified by Parametric Response Mapping in Patients With Lung Cancer Before Radiation Treatment, Adv Radiation Oncology, 2022 Apr 25;7(4):100980, PMID: 35693252, PMCID: PMC9184868, doi: 10.1016/j.adro.2022.100980
  • Herr et al, Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Patients With Lung Cancer Receiving Definitive Radiation Therapy Across a Statewide Consortium, Pract Radia Oncol, 2022 Feb 1;S1879-8500(22)00007-8, PMID: 35121192, doi: 10.1016/j.prro.2022.01.002.
  • Polan D, Epelman M, Wu V, Sun Y, Varsta M, Owen D, Jarema D, Matrosic C, Jolly S, Schonewolf C, Schipper M, Matuszak M, Direct incorporation of patient-specific efficacy and toxicity estimates in radiation therapy plan optimization, Med Phys, 2022 Oct;49(10):6279-6292, PMID: 35994026PMC9826508, doi: 10.1002/mp.15940. Epub 2022 Sep 2
  • Covert E, Kitzpatrick K, Mikell J, Kaza R, Millet J, Barkmeier D, Gemmete J, Christensen J, Schipper M, Dewaraja Y, Intra- and inter-operator variability in MRI-based manual segmentation of HCC lesions and its impact on dosimetry, EJNMMI Phys, 2022 Dec 21;9(1):90, PMID: 36542239PMC9772368, doi: 10.1186/s40658-022-00515-6
  • Cher B, Dykstra M, Wang C, Schipper M, Hayman J, Mayo C, Jagsi R, Trends in Radiation Oncology Treatment Fractionation at a Single Academic Center, 2010 to 2020, Adv Radiation Oncology, 2022 Jul 22;7(6):101032, PMID: 36072755PMC9441303, doi: 10.1016/j.adro.2022.101032
  • Cousins M, VanTil M, Steppe E, Ng S, Ellimoottil C, Sun Y, Schipper M, Evans J, Age, race, insurance type, and digital divide index are associated with video visit completion for patients seen for oncologic care in a large hospital system during the COVID-19 pandemic, PLoS One, 2022 Nov 17;17(11):e0277617, PMID: 36395112PMC9671352, doi: 10.1371/journal.pone.0277617
  • Mierzwa M, Aryal M, Lee C, Schipper M, VanTil M, Morales K, Swiecicki P, Casper K, Malloy K, Spector M, SHuman A, Chinn S, Prince M, Stucken C, Rosko A, Lawrence T, Brenner J, Rosen B, Schonewolf C, Shah J, Eisbruch A, Worden F, Cao Y, Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer, Clin Cancer REs, 2022 Dec 1;28(23):5049-5057, PMID: 36107219PMC9773159, doi: 10.1158/1078-0432.CCR-22-1522
  • Jagsi R, Griffith K, Vicini F, Boike T, Dominello M, Gustafson G, Hayman J, Moran J, Radawski J, Walker E, Pierce L, Identifying Patients Whose Symptoms Are Underrecognized During Treatment With Breast Radiotherapy, JAMA Oncology, 2022 Jun 1;8(6):887-894, PMID: 35446337PMC9026246, 2022 Jun 1;8(6):887-894
  • Vince R, Jiang R, Qi J, Tosoian J, Takele R, Feng F, Linsell S, Johnson A, Shetty S, Hurley P, Miller D, George A, Ghani K, Sun F, Seymore M, Dess R, Jackson W, Schipper M, Spratt D, Morgan T, Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative, Prostate Cancer Prostatic Dis, 2022 Apr;25(4):677-683, PMID: 34285350PMC8770695, doi: 10.1038/s41391-021-00428-y
  • Jagsi R, Schipper M, Mietzel M, Pandya R, Moran J, Matuszak M, Vicini F, Jolly J, Paximadis P, Mancini B, Griffith K, Hayman J, Pierce L, The Michigan Radiation Oncology Quality Consortium: A Novel Initiative to Improve the Quality of Radiation Oncology Care, Int J Radiat Oncol Biol Phys, 2022 Jun 1;113(2):257-265, PMID: 35124133, doi: 10.1016/j.ijrobp.2022.01.048
  • Hinton et al, Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysis, Trans Oncol, 2022 Jul;21:101428, PMID: 35460942, PMCID: PMC9046881, doi: 10.1016/j.tranon.2022.101428
  • Qin et al, ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization, Cell Rep, 2022 Jan 11;38(2):110216, PMID: 35021084, PMCID: PMC8759735, doi: 10.1016/j.celrep.2021.110216
  • Qin et al, Comprehensive enhancer-target gene assignments improve gene set level interpretation of genome-wide regulatory data, Genome Biol, 2022 Apr 26;23(1):105, PMID: 35473573, PMCID: PMC9044877, doi: 10.1186/s13059-022-02668-0
  • Van Poznak et al, Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer, Oral Dis, 2022 Jan;28(1):193-201, PMID: 33274559, PMCID: PMC8284838 , doi: 10.1111/odi.13746
  • Chen D, Rob F, Mukherjee R, Girodano T, Haymart M, Banerjee M, Variation in the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features, J Clin Endocrinol Metab, 2022 Sep 28;107(10):e4072-e4077, PMID: 35918064, PMCID: PMC9516041, doi: 10.1210/clinem/dgac466
  • Koshkin et al, Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study, Cancer, 2022 Mar 15;128(6):1194-1205, PMID: 34882781, doi: 10.1002/cncr.34057
  • Lussiez et al, A multi-modal study examining long-term bowel, urinary, and sexual function after rectal cancer surgery, Am J Surg, 2022 Jul;224(1 Pt B):562-568, PMID: 35260231, doi: 10.1016/j.amjsurg.2022.02.046
  • Radhakrishnan et al, Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities, J Clin Endocrinol Metab, 2022 Feb 17;107(3):e1096-e1105, PMID: 34718629, PMCID: PMC8852205 , doi: 10.1210/clinem/dgab781
  • Radhakrishnan et al, Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer, J Urol, 2022 May 6;101097JU0000000000002734, PMID: 35522191, PMCID: PMC9378546, doi: 10.1097/JU.0000000000002734
  • Berlin et al, Perceived financial decline related to breast reconstruction following mastectomy in a diverse population-based cohort, Cancer , 2022 Mar 15;128(6):1284-1293, PMID: 34847259, PMCID: PMC8882150 , doi: 10.1002/cncr.34048.
  • Kurian et al, Chemotherapy Regimens Received by Women with BRCA1/2 Pathogenic Variants for Early-Stage Breast Cancer Treatment, JNCI Cancer Spectr, 2022 Jun 20;pkac045, PMID: 35723570, PMCID: PMC9305849, doi: 10.1093/jncics/pkac045
  • Suwanabol P, Li Y, Abrahamse P, Roo A, Vu J, Milveira M, Mody L, Dimick J, Functional and Cognitive Decline Among Older Adults After High-risk Surgery, Ann Surg, 2022 Jan 1;275(1):e132-e139, PMID: 32404660, PMCID: PMC8060894 , doi: 10.1097/SLA.0000000000003950
  • Veensta C, Ellis K, Abrahamse P, Ward K, Morris A, Hawley S, A dyadic survey study of partner engagement in and patient receipt of guideline-recommended colorectal cancer surveillance, BMC Cancer, 2022 Oct 13;22(1):1060., PMID: 36339796, PMCID: PMC9559022, doi: 10.1186/s12885-022-10131-3
  • Kurian A, Abrahamse P, Bondarenko I, Hamilton A, Deapen D, Gomez S, Morrow M, Berek J, Hofer T, Katz S, Ward K, Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer, J Natl Cancer Inst, 2022 Feb 7;114(2):245-253, PMID: 34373918, PMCID: PMC8826508 , doi: 10.1093/jnci/djab151
  • Veenstra C, Braun T, Abrahamse P, Wittman D, Hawley S, Employment outcomes in family supporters of patients with early stage breast cancer and their association with patients' health-related quality of life and financial burden, Cancer Med, 2022 Mar;11(5):1324-1335, PMID: 35112499, PMCID: PMC8894687, doi: 10.1002/cam4.4513
  • Kohne J, MacLaren G, Cagino L, Boonstra P, Brodie D, Barbaro R, Tracheostomy Practices and Outcomes in Patients With COVID-19 Supported by Extracorporeal Membrane Oxygenation: An Analysis of the Extracorporeal Life Support Organization Registry, Crit Care Med, 2022 Sep 1;50(9):1360-1370, PMID: 35607973, PMCID: PMC9380152, doi: 10.1097/CCM.0000000000005579
  • Li et al, Utility based approach in individualized optimal dose selection using machine learning methods, Statistics in Medicine, 2022 Jul 20;41(16):2957-2977, PMID: 35343595PMC9233043, doi: 10.1002/sim.9396
  • Abghari-Gerst et al, A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients, Journal of Nuclear Medicine, 2022 Apr;63(4):567-572, PMID: 34326126PMC8973291, doi: 10.2967/jnumed.121.262412
  • Guo C, Kang J, Johnson T, A spatial Bayesian latent factor model for image-on-image regression, Biometrics, 2022 Mar;78(1):72-84, PMID: 33368210PMC8236065, doi: 10.1111/biom.13420
  • Whiteman et al, Bayesian Inference for Brain Activity from Functional Magnetic Resonance Imaging Collected at Two Spatial Resolutions, Annals of Applied Statistics, 2022 Dec;16(4):2626-2647, PMID: 36338823PMC9629780, doi: 10.1214/22-aoas1606
  • Messinger et al, Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma, Neuro Oncol, 2022 May 23;noac141, PMID: 35605606, doi: 10.1093/neuonc/noac141
  • Frame et al, Defibrotide Therapy for SARS-CoV-2 ARDS, Chest, 2022 Apr 9;S0012-3692(22)00593-1, PMID: 35413279, PMCID: PMC8993696, doi: 10.1016/j.chest.2022.03.046
  • Wittman et al, TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results, Cancer, 2022 Apr 1;128(7):1513-1522, PMID: 34985771, doi: 10.1002/cncr.34076
  • Braun T, Mercier F, Extending the Continual Reassessment Method to accommodate step-up dosing in Phase I trials, Stat Med , 2022 Sep 10;41(20):3975-3990, PMID: 35662077, PMCID: PMC9546169, doi: 10.1002/sim.9487
  • Raj M, Gupta V, Hoodin F, Clingan C, Roslin C, Yahng L, Braun T, Choi S, Evaluating mobile Health technology use among cancer caregivers in the digital era, Digital Health, 2022 Jun 22;8:20552076221109071, PMID: 35769358, PMCID: PMC9234853, doi: 10.1177/20552076221109071
  • Qazilbash M, Saini N, Cha S, Wang Z, Stadtmauer E, Baladandayuthapani V, Lin H, Tross B , Honhar M, Rao S, Kim K, Popescu M, Szymura S, Zhang T, Anderson A, Bashir Q, Shpall E, Orlowski R, Levine B, Kerr N, Garfall A, Cohen A, Vogl D, Dengel K, June C, Champin R, Kwak L, A randomized phase 2 trial of idiotype vaccination and adoptive autologous T-cell transfer in patients with multiple myeloma, Blood, 2022 Mar 3;139(9):1289-1301, PMID: 34521108, PMCID: PMC8900281 , doi: 10.1182/blood.2020008493
  • Tanaka I, Dayde D, Tai M, Mori H, Solis L, Tripahi S, Fahrmann J, Unver N, Parhy G, Jain R, Parra E, Murakami Y, Aguilar-Bonavides C, Mino B., Celiktas M, Shillon D, Casabar J, Nakatochi M, Stingo F, Baladandayuthapani V et al, SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas, J Natl Cancer Inst, 2022 Feb 7;114(2):290-301, PMID: 34524427, PMCID: PMC8826620 , doi: 10.1093/jnci/djab183
  • Ni Y, Baladandayuthapani V, Vannucci M, Stingo F, Bayesian graphical models for modern biological applications, Stat Methods Appt, 2022;31(2):197-225, PMID: 35673326, PMCID: PMC9165295, doi: 10.1007/s10260-021-00572-8
  • Ma V, Perera C, Sun Y, Sitto M, Waninger J, Warrier G, Green M, Fecher L, Lao C, Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab, Front Immunology, 2022 Jul 6;13:860421, PMID: 35874737, PMCID: PMC9296775, doi: 10.3389/fimmu.2022.860421
  • Hirschtick J, Cook S, Patel A, Barnes G, Arenberg D, Bondarenko I, Levy D, Jeon J, Medoza E, Meza R, Fleischer N, Longitudinal associations between exclusive and dual use of electronic nicotine delivery systems and cigarettes and self-reported incident diagnosed cardiovascular disease among adults, Nicotine Tob Res, 2022 Jul 30;ntac182, PMID: 35907264, PMCID: , 2022 Jul 30;ntac182
  • Li G, Xu S, Yang S, Wu C, Zhang L, Wang H, An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma, Front Genet, 2022 Dec 8;13:1029576, PMID: 36568382, PMCID: PMC9773198, doi: 10.3389/fgene.2022.1029576
  • Ma L, Li G, Yang T, Zhang L, Wang X, Xu X, Hi H, An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16, Cancer Chemother Pharmacol, 2022 Dec;90(6):431-444, PMID: 36224471, PMCID: PMC9637061, doi: 10.1007/s00280-022-04483-7

  • Lee J, Wang N, Turk S, Mohammed S, Lobo R, Kim J, Liao E, Camelo-Piragua S, Kim M, Junck L, Bapuraj J, Srinivasan A, Rao A, Discriminating Pseudoprogression and True Progression in Diffuse Infiltrating Glioma using Multi-parametric MRI data through Deep Learning. Scientific Reports, 2020;10(1):20331, PMID: 33230285 Steele, N.G, et al. Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer. Clinical Cancer Research (2020). (in press)
  • Caissie A, Mierzwa M, Fuller C et al. Radiotherapy (RT) Patterns Of Practice Variability Identified As A Challenge To Real-World Big Data: Recommendations From The Learning From Analysis Of Multicenter Big Data Aggregation (LAMBDA) Consortium. International Journal of Radiation Oncology*Biology*Physics. 2020;108(3):e773-e774. doi:10.1016/j.ijrobp.2020.07.224
  • Steele N, Carpenter E, Kemp S et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat Cancer. 2020;1(11):1097-1112. doi:10.1038/s43018-020-00121-4
  • Carpenter E, Steele N, Kemp S et al. S0002 Developing a Multimodal Platform for Precision Medicine Using Endoscopic Fine Needle Biopsies in Pancreatic Cancer. American Journal of Gastroenterology. 2020;115(1):S1-S1. doi:10.14309/01.ajg.0000697892.97250.42
  • Li T, Tripathi A, Yu F, Sherman D, Rao A. DDAP: docking domain affinity and biosynthetic pathway prediction tool for type I polyketide synthases.Bioinformatics. 2019. doi:10.1093/bioinformatics/btz677
  • Mayo C, Mierzwa M, Moran J et al. Combination of a Big Data Analytics Resource System With an Artificial Intelligence Algorithm to Identify Clinically Actionable Radiation Dose Thresholds for Dysphagia in Head and Neck Patients. Adv Radiat Oncol. 2020;5(6):1296-1304. doi:10.1016/j.adro.2019.12.007

 
  • Bankhead III A, McMaster T, Wang Y, Boonstra PS, Palmbos PL: “TP63 Isoform Expression is Linked with Distinct Clinical Outcomes in Cancer”  EBioMedicine 2020, 51, 10256.
  • Beeler WH, Bellile EL, Casper KA, Jaworski E, Burger NJ, Malloy KM, Spector ME, Shuman AG, Rosko A, Stucken CL, Chinn SB, Dragovic AF, Chapman CH, Owen D, Jolly S, Bradford CR, Prince MEP, Worden FP, Jagsi R, Mierzwa ML, Swiecicki PL: “Patient-reported financial toxicity and adverse medical consequences in head and neck cancer”, Oral Oncol, 101:104521, doi: 10.1016/j.oraloncology.2019.104521, Epub ahead of print, PMID: 31877502.
  • Caram MEV, Ross R, Lin P, Mukherjee B: “Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer” JAMA Open Network, 2 (4), e192589-e192589. 2019.
  • Cheng, W, Taylor JMG, Gu T, Tomlins SA, Mukherjee B “Informing a Risk Prediction Model for Binary Outcomes with External Coefficient Information” Journal of Royal Statistical Society, 2019 Jan, 68(1): 121-139. PMC6519970.
  • Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Schipper MJ*, Spratt DE*. *Contributed Equally: “Association of Black Race with Prostate Cancer-Specific and Other-Cause Mortality” JAMA Oncology: 2019. PMC6547116.
  • Dewaraja YK, Devasia T, Kaza RK, Mikell JK, Owen D, Roberson PL and Schipper MJ: “Accurately predicting tumor control in 90Y radioembolization by logit models with PET/CT based dose metrics” Journal Nuclear Medicine: 2019. PMC6954459.
  • Eich ML, Chandrashekar DS, Rodriguez P, Robinson AD, Siddiqui J, Daignault-Newton S, Chakravarthi B, Kunju LP, Netto GH, Varambaly S: “Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer” Prostate, 2019 Oct; 79(14): 1629-1639.
  • Ettel M, Zhao L, Schechter S, Shi J; “Expression and prognostic value of NSD1 and SETD2 in pancreatic ductal adenocarcinoma and its precursor lesions.” Pathology. 2019. PMC6544165.
  • Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI, Shaheen NJ, Kresty LA, Chak A, Wang TD, Rubenstein JH, Beer DG. “Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage” Gastroenterology. 2019 Apr;156(5):1404-1415.PMCID: PMC6441633.
  • Frydrych L, Ulintz P, Bankhead III A, Greenson J, Maguire L, Sifuentes CJ, Fearon E, Hardiman KM:  “Rectal Cancer Sub-Clones Respond Differentially to Neoadjuvant Therapy” Neoplasia 2019, 21(10):1051-1062.
  • Gates EDH, Lin JS, Weinberg JS, Hamilton J, Prabhu SS, Hazle JD, Fuller GN, Baladandayuthapani V, Fuentes D, Schellingerhout D: “Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging”, Neuro Oncol, 2019, 21(4): 527-536.
  • Hawkins PG, Sun Y, Dess RT, Jackson WC, Sun G, Bi N, Tewari M, Hayman JA, Kalemkerian GP, Gadgeel SM, Lawrence TS, Haken RKT, Matuszak MM, Kong FS, Schipper MJ, Jolly S: “Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.” J Cancer Res Clin Oncol: 2019. PMC6956699.
  • Kamdem LK, Xi  J, Clark BL, Gregory BJ, Kidwell KM, Storniolo AM, Stearns V, Hayes DF, Gersch CL, Rae JM, Henry NL, Hertz DL; “Exemestane may be less detrimental than letrozole to bone health in women homozygous for UGT2B17*2 gene deletion.” Breast Cancer Research and Treatment, 2019. PMC6534458.
  • Katz SJ, Bondarenko I, Ward KC.: “Association of attending surgeon with variation in the receipt of genetic testing after diagnosis of breast cancer “(vol 153, pp 909, 2018). JAMA Surgery. ,154(3): p.272, 2019.
  • Kim MM, Speers C, Li P, Schipper M, Junck L, Leung D, Orringer D, Heth J, Umemura Y, Spratt DE, Wahl DR, Cao Y, Lawrence TS, Tsien CI: “Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.” J Neurooncol: 2019. PM30977058. [Epub ahead of print]
  • Kim RY, Helman JI, Braun TM, and Ward BB. “Does Perineural Invasion, a Negative Predictor of Outcome in Oral Squamous Cell Carcinoma, Have Site-Specific Correlation?” Head & Neck (77): 852-858, 2019.
  • Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Mukherjee B: “A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide significant common variants” International Journal of Cancer, 144 (9), 2192-2205. 2019.
  • Lee W, Miranda MF, Rausch P, Baladandayuthapani V, Fazio M, Downs JC, Morris JS: “Bayesian Semiparametric Functional Mixed Models for Serially Correlated Functional Data, with Application to Glaucoma Data”, J AM Stat Assoc, 2019, 114(526): 495-513.
  • Lu T, Bankhead III A, Ljungman M, Neamati N. “Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3” Theranostics 2019; 9(19):5478-5496.
  • Luo X, Donnelly CR, Gong W, Heath BR, Hao Y, Donnelly LA, Moghbeli T, Tan YS, Lin X, Bellile E, Kansy BA, Carey TE, Brenner JC, Cheng L, Polverini PJ, Morgan MA, Wen H, Prince ME, Ferris RL, Xie Y, Young S, Wolf GT, Chen Q, Lei YL: “HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING”, J Clin Invest, Epub ahead of print, doi: 10.1172/JCI129497, PMID: 31874109.
  • Ma X, Kang X, He L, Zhou J, Zhou J, Sturm MB, Beer DG, Kuick RD, Nancarrow DJ, Appelman HD, Pang Z, Li W, Zhang C, Zhang W, Zhang Y, Wang TD, Li M. “Identification of tumor specific peptide as EpCAM ligand and its potential diagnostic and therapeutic clinical application” Mol Pharm. 2019 May 6;16(5):2199-2213. PMID: 30974945.
  • Maity AK, Bhattacharya A, Ballick BK, Baladandayuthapani V: “Bayesian data integration and variable selection for pan-cancer survival prediction using protein expression data”, Biometrics, 2019, Epub ahead of print, PMID: 3139300.
  • Manasanch EE, Han G, Mathur R, Qing Y, Zhang Z, Lee H, Weber DM, Amini B, Berkova Z, Eterovic K, Zhang S, Zhang  J, Song X, Mao X, Morgan M, Feng L, Baladandayuthapani V, Futreal A, Wang L, Neelapu SS, Orlowski RZ: “A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune and genomic analysis”, Blood Adv, 2019, 3(15): 2400-2408.
  • Manton T, Tillman B, McHugh J, Bellile E, McLean S, McKean E. “Sinonasal Melanoma: A Single Institutional Analysis and Future Directions” J Neurol Surg B Skull Base. 2019 Oct;80(5):484-492. doi: 10.1055/s-0038-1676355. PMCID: PMC6748852.
  • Marisetty AL, Lu L, Veo BL, Liu B, Coarfa C, Kamal MM, Kassem DH, Irshad K, Lu Y, Gumin J, Henry V, Paulucci-Holthauzen A, Rao G, Baladandayuthapani V, Lang FF, Fuller GN, Majumder S: ” REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis”, Neuro Oncol, 2019, 21(6): 775-785.
  • McCool K, Freeman ZT, Zhai Y, Wu R, Hu K, Liu CJ, Tomlins SA, Fearon ER, Magnuson B, Kuick R, Cho KR. “Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts” Cancer Res. 2019 Dec 5. doi: 10.1158/0008-5472.CAN-19-2558. [Epub ahead of print] PMID:31806642.
  • Michmerhuizen NL, Leonard E, Matovina C, Harris M, Herbst G, Kulkarni A, Zhai J, Jiang H, Carey TE, Brenner JC, “Rationale for using irreversible EGFR Inhibitors in combination with PI3K inhibitors for advanced Head and Neck Squamous Cell Carcinoma.” Molecular Pharmacology, doi: 10.1124/mol.118.115162, 2019. PMC6442321.
  • Muenz D, Taylor JMG, Braun T: “Phase I/II Trial Design for Biologic Agents using CAR Models for Toxicity & Efficacy.” Journal of the Royal Statistical Society, Series C (68): 331-345, 2019.
  • Nez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu AA, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, Venneti S, BrosnanCashman J, Meeker A, Gorbunova V, Zhao L, Kremer DM, Zhang L, Lyssiotis CA, Jones L, Herting CJ, Ross JL, Hambardzumyan D, Hervey-Jumper S, Figueroa ME, Lowenstein PR, Castro MG; “IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.” Sci Transl Med., 11(479). 2019.
  • Ni Y, Stingo FC, Ha MJ, Akbani R, Baladandayuthapani V: “Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics”, J Am Stat Assoc, 2019, 114(525): 48-60.
  • Palmbos P, Wang Y, Bankhead III A, Kelleher A, Wang L, Yang H, Ahmet M, Gumkowski E, Welling S, Magnuson B, Leflein J, Lorenzatti G, Abel E, Dziubinski M, Urs S, Day M, Ljungman M, Simeone D, “ATDC mediates a TP63-regulated basal cancer invasive program” Oncogene, 1476-5594, 2019. PMC6290910.
  • Rozek  L., Virani S., Bellile E., Taylor JMG, Sartor M., Zarins K., Virani A., Cote C., Worden F., Prince M., McLean S., Duffy S., Yoo G., Saba N., Shin D., Kucuk O., Wolf G.T., “Soy Isoflavone Supplementation Increases Long Interspersed Nucleotide Element-1 (LINE-1) Methylation in Head and Neck Squamous Cell Carcinoma”, Nutrition and Cancer, 71(5), 772-780, 2019.
  • Spector ME, Bellile E, Amlani L, Zarins K, Smith J, Brenner JC, Rozek L, Nguyen A, Thomas D, McHugh JB, Taylor JMG, Wolf GT. “Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma” JAMA Otolaryngol Head Neck Surg. 2019 Sep 5;. doi: 10.1001/jamaoto.2019.2427. Epub ahead of print. PMCID: PMC6735419.
  • Tang J, Feng Y, Kuick R, Green M, Green M, Sakamoto N, Kurosu Y, Lin J, Cho KR, Fearon ER. “Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis” Lab Invest. 2019 Oct;99(10):1454-1469. Epub 2019 May 31. PMCID:PMC6759392.
  • Taylor JMG, Shuman AG, Beesley LJ, “Individualized prognostic calculators in the precision oncology era” Oncotarget 10 (4), 415. 2019.
  • Veenstra C, Wallner L, Abrahamse P; Janz N, Katz S, Hawley S; “Understanding the engagement of key decision support persons in patient decision making around breast cancer treatment.” Cancer,  2019. PMC6486440.
  • Wallner L, Li Y, McLeod M, Gargaro J, Kurian A, Jagsi R, Radhakrishnan A, Hamilton A, Ward K, Hawley S, Katz S. “Primary care provider–reported involvement in breast cancer treatment decisions.” Cancer, 2019, 125: 1815-1822. PMC6509002.
  • Wang Y, Kim TH, Fouladdel S, Zhang Z, Soni P, Qin A, Zhao L, Azizi E, Lawrence TS, Ramnath N, Cuneo KC, Nagrath S; “PD-L1 Expression in Circulating Tumor Cells Increases during Radio(chemo)therapy and Indicates Poor Prognosis in Non-small Cell Lung Cancer.” Sci Rep., 9(1):566. 2019.
  • Wang Y, Sessine MS, Zhai Y, Tipton C, McCool K, Kuick R, Connolly DC, Fearon ER, Cho KR. “Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium” J Pathol. 2019 Oct;249(2):206-214. Epub 2019 Jul 8. PMID:31131879.
  • Wang F, Duan X, Chen J, Gao Z, Zhou J, Wu X, Chang TS, Lee M, Li G, Nusrat A, Kuick R, Appelman HD, Wang TD. “Integrated Imaging Methodology Detects Claudin-1 Expression in Premalignant Nonpolypoid and Polypoid Colonic Epithelium in Mice” Clin Transl Gastroenterol. 2020 Jan 9. doi: 10.14309/ctg.0000000000000089. [Epub ahead of print] PMID:31922993.
  • Wu X, Zhou J, Wang F, Meng X, Chen J, Chang TS, Lee M, Li G, Li X, Appelman HD, Kuick R, Wang TD. “Detection of colonic neoplasia in vivo using near-infrared-labeled peptide targeting cMet” Sci Rep. 2019 Nov 29;9(1):17917. PMCID:PMC6884535.
  • Xu S, Liu Y, Yang K, Wang H, Shergalis A, Kyani A, Bankhead III A, Tamura S, Yang S, Wang X, Wang CC, Rehemtulla A, Ljungman M, Neamati N. “Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genes” Theranostics 2019; 9(8):2282-2298.
  • Zhou Q, Li H, Li Y, Tan M, Fan S, Cao C, Meng F, Zhu L, Zhao L, Guan MX, Jin H, Sun Y; “Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells.” JCI Insight, 4(4):121582. 2019.
  • Zick S, Sen A, Hassatt A, Schrepf A, Wyatt G, Murphy S, Arnedt J, Harris R; “Impact of Self-Acupressure on Co-Occurring Symptoms in Cancer Survivors” JNCI Cancer Spectrum ; 2 (4); 2019.

 
  • Abel EV, Goto M, Magnuson B, Abraham S, Ramanathan N, Hotaling E, Alaniz AA, Kumar-Sinha C, Dziubinski ML, Urs S, Wang L, Shi J, Waghray M, Ljungman M, Crawford HC, Simeone DM. “HNF1A is a novel oncogene that regulates human pancreatic cancer stem cell properties”. 2018. Elife. PMID: 3007447.
  • Altan M, Kidwell KM, Pelekanou V, Carvajal-Hausdorf DE, Schalper KA, Toki M, Thomas DG, Sabel MS, Hayes DF, Rimm DL; “Associations of B7-H4, PD-L1 and tumor infiltrating lymphocytes with outcomes in breast cancer.”  NPJ Breast Cancer. Dec 10: 4:40, 2018.
  • Anwar T, Arellano-Garcia C, Ropa J, Chen Y, Kim H, Yoon E, Grigsby S, Basrur V, Nesvizhskii A, Muntean A, Gonzalez M, Kidwell K, Nikolovska-Coleska Z, Kleer C; “p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis.” Nature Communications. 9(1):2801, 2018.
  • Banerjee M, Reyes-Gastelum D, Haymart MR. “Treatment-free Survival in Patients with Differentiated Thyroid Cancer.” Journal of Clinical Endocrinology and Metabolism, 103:2720-2727, 2018. PMID: 29788217.
  • Beesley LJ, Morgan TM, Spratt DE, Singhal U, Feng FY, Furgal AC, Jackson WC, Daignault S, Taylor JMG: “Individual and Population Comparisons of Surgery and Radiotherapy Outcomes in Prostate Cancer Using Bayesian Multistate Models.”, JAMA Open Network, 2(2): e187765. 2018, PMC6484613.
  • Beesley LJ, Hawkins P, Amlani LH, Bellile E, Casper KA, Chinn SB, Eisbruch A, Mierzwa ML, Spector ME, Wolf GT, Shuman AG, Taylor JMG: “Individualized Survival Prediction for Patients with Oropharyngeal Cancer in the Human Papillomavirus Era” Cancer, 125(1):68-78, 2018. PMC6309492.
  • Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy S, Henry NL; “Effect of aromatase inhibitor therapy on sleep and activity patterns in early stage breast cancer.” Clinical Breast Cancer. 18(2): 168-174, 2018.
  • Caram M, Wang S,Tsao P, Griggs JJ, Miller DC, Hollenbeck BK, Lin P, Mukherjee B: “Patient and Provider Variables Associated with Variation in the Systemic Treatment of Advanced Prostate Cancer” Urology Practice, 10.1097/UPJ. 0000000000000020. 2018.
  • Caram  MEV, Estes JP, Griggs JJ, Lin P, Mukherjee B: “Temporal and geographic variation in the systemic treatment of advanced prostate cancer” BMC cancer 18 (1), 258. 2018.
  • Castillo CG, Kauffman CA, Zhai J, Jiang H, Agozino SM, Miceli MH: “Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.” Mycoses, 61(1):4-10, 2018, PMID: 28905439.
  • Colacino JA, Azizi E, Brooks MD, Harouaka R, Fouladdel S, McDermott SP, Lee M, Hill D, Madden J, Boerner J, Cote ML, Sartor MA, Rozek LS, Wicha MS: “Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling.” Stem Cell Reports, 10(5):1596-1609, 2018, PMC5995162.
  • Cuneo KC, Morgan MA, Griffith KA, Hawkins PG, Greenson JK, Ben-Josef E, Lawrence TS, and Zalupski MM: “Prognostic Value of c-MET Expression in Patients with Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy.” Int J Radiat Oncol Biol Phys, 100(2):490-497, 2018, PMID: 29229329.
  • Davis EJ, Griffith KA, Kim EJ, Ruch JM, McDonnell KJ, and Zalupski MM: “A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers.” Am J Clin Oncol, 41(2):128-132, 2018, PMC4854803.
  • Dess RT, Devasia TP, Aghdam N, Jackson WC, Soni PD, Smith CP, Mitchell AL, Suy S, Hamstra DA, Jolly S, Nguyen PL, Feng FY, Schipper MJ, Skolarus TA, Miller DC, Wittmann DA, Collins SP, Spratt DE: “Patient-Reported Sexual Aid Utilization and Efficacy After Radiation Therapy for Localized Prostate Cancer.” Int J Radiat Oncol Biol Phys, 101(2):376-386, 2018, PMID: 29487023.
  • Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB, Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt DE: “Erectile Function after Stereotactic Body Radiotherapy for Prostate Cancer: Comparison to Nerve-Sparing Prostatectomy and Conventional Radiotherapy.” BJU Int, 121(1):61-68, 2018, PMID: 28710895.
  • El Naqa I, Ruan D, Valdes G, Dekker A, McNutt T, Ge Y, Wu QJ, Oh JH, Thor M, Smith W, Rao A, Fuller C, Xiao Y, Manion F, Schipper M, Mayo C, Moran JM, Ten Haken R: Machine learning and modeling: Data, validation, communication challenges. Med Phys 45(10): e834-e840, 2018. PMC6181755.
  • Feng M, Suresh K, Schipper MJ, Bazzi L, Ben-Josef E, Matuszak MM, Parikh ND, Welling TH, Normolle D, Ten Haken RK, Lawrence TS: “Individualized Adaptive Sterotactic Body Radiotherapy (SBRT) for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.” JAMA Oncol, 4(1):40-47, 2018, PMC5766368.
  • Ferrer-Torres D, Nancarrow DJ, Steinberg H, Wang Z, Kuick R, Weh KM, Mills RE, Ray D, Ray P, Lin J, Chang AC, Reddy RM, Orringer MB, Canto MI, Shaheen NJ, Kresty LA, Chak A, Wang TD, Rubenstein JH, Beer DG: “Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.” Gastroenterology, S0016-5085(18)35401-5, Dec 12 2018. PMID: 30578782.
  • Fritsche L, Beesley L, VandeHaar P, Peng R, Salvatore M, Zawistowski M, Taliun S, LeFaive J, Kaleba E, Klumpner T, Moser S, Blanc V, Mukherjee B: “Exploring various polygenic risk scores for skin cancer in the phenomes of the Michigan genomics initiative and the UK Biobank with a visual catalog: PRSWeb”. Plos Genetics, 2019 June 13; 15(6):e1008202.
     
  • Hawkins PG*, Boonstra PS*, Hobson ST, Hayman JA, Ten Haken RK, Matuszak MM, Stanton P, Kalemkerian GP, Lawrence TS, Schipper MJ, and Jolly S; ”Prediction of radiation esophagitis in non-small cell lung cancer using clinical factors, dosimetric parameters, and pretreatment cytokine levels.” Translational Oncology 11, 102–108. 2018. *Equal contribution authors PMC6002355.
  • Hawkins PG, Tang M, Vineberg KA, Young L, Kovach K, Lee C, Maturen KE, Uppal S, Owen D, Schipper MJ, Prisciandaro JI, Jolly S: “Dosimetric impact of interfractional organs at risk variation during high-dose rate interstitial brachytherapy for gynecologic malignancies.” Med Dosim: 2018. PM30336971.
  • Healy MA, Morris AM, Abrahamse P, Ward KC, Kato I, Veenstra CM: “The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.” BMC Cancer, 18(1):481, 2018,PMC5924509.
  • Heiden BT, Patel N, Nancarrow DJ, Hermann M, Brown RKJ, Orringer MB, Lin J, Chang AC, Carrott PW, Lynch WR, Zhao L, Beer DG, Reddy RM; “Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake Correlates with KRAS and EMT Gene Signatures in Operable Esophageal Adenocarcinoma.” J Surg Res., 232:621-628. 2018.
  • Henry NL, Kidwell KM, Alsamarraie C, Bridges C, Kwiatkowski Clauw D, Smith E, Williams D; “Pilot study of a proactive self-management program for symptom management in patients with breast cancer.” Journal of Clinical Oncology Clinical Cancer Informatics. 2:1-12, 2018.
  • Hertz DL, Kidwell KM, Vangipuram K, Li F, Pai MP, Burness M, Griggs JJ, Schott AF, Van Poznak C, Hayes DF, Smith EML, Henry NL; “Paclitaxel Plasma Concentration After the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy.” Clinical Cancer Research. 24(15): 3602-3610, 2018, PMC6386454.
  • Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG: “Individualized outcome prognostication for patients with laryngeal cancer.” Cancer, 12494):706-716, 2018, PMC5800991.
  • Hussain M, Daighault-Newton S, Twardowski PW, Albany C, Stein MN, Kunju LP, Siddiqui J, Wu YM, Robinson D, Lonigro RJ, Cao X, Tomlins SA, Mehra R, Cooney KA, Montgomery B, Antonarakis ES, Shevrin DH, Corn PG, Whang YE, Smith DC, Caram MV, Knudsen KE, Stadler WM, Feng FY, Chinnaiyan AM: “Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.” 36(10):991-999, J Clin Oncol, PMID: 29261439.
  • Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, Hamstra DA: A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life. Pract Radiat Oncol 8(1): 40-47, 2018. PM29304991.
  • Jackson WC, Suresh K, Tumati V, Allen SG, Dess RT, Salami SS, George A, Kaffenberger SD, Miller DC, Hearn JWD, Jolly S, Mehra R, Hollenbeck BK, Palapattu GS, Schipper M, Feng FY, Morgan TM, Desai NB, Spratt DE: “Intermediate Endpoints After Postprostatectomy Radiotherapy: 5-Year Distant Metastasis to Predict Overall Survival.” Eur Urol: 2018. PM29306514.
  • Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo KC, Lawrence TS, Owen D: “Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases.” Int J Radiat Oncol Biol Phys 100(4): 950-958, 2018. PM29485074.
  • Jagsi R, Griffith KA, Bellon J, Woodward W, Horton J, Ho A, Feng F, Speers C, Overmoyer B, Sabel M, Schott A, and Pierce LJ for the Translational Breast Cancer Research Consortium: “Concurrent Veliparib with Chest Wall and Nodal Radiation Therapy in Patients with Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study.” J Clin Oncol, 36(13):1317-1322, 2018, PMID: 29558281.
  • Jagsi R, Ward K, Abrahamse P, Wallner L, Kurian A, Hamilton A, Katz S, Hawley S, “Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer.” Cancer, 124(18)3668-3676. 2018.
  • Jin X, Qin T, Zhao M, Bailey N, Liu L, Yang K, Ng V, Higashimoto T, Coolon R, Ney G, Figueroa ME, Li Q: “Oncogenic N-Ras and Tet2 haploinsufficiency collaborate to dysregulate hematopoietic stem and progenitor cells.” Blood Adv, 2(11):1259-1271, 2018, PMC5998937.
  • Kanters AE, Morris AM, Abrahamse PH, Mody L, Suwanabol PA: “The Effect of Peer  Support on Colorectal Cancer Patients' Adherence to Guideline-Concordant Multidisciplinary Care.” Dis Colon Rectum, 61(7):817-823, 2018, PMC5992023.
  • Katz S, Ward K, Hamilton A, Abrahamse P, Hawley S, Kurian A, “Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer.”  JCO Precision Oncology,  2018.
  • Kidwell KM, Postow MA, Panageas KS; “Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-Oncology Research.” Clinical Cancer Research. 24(4): 730-736, 2018.
  • Koneva LA, Zhang Y, Virani S, Hall PB, McHugh JB, Chepeha DB, Wolf GT, Carey TE, Rozek LS, Sartor MA: “HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.” Mol Cancer Res, 16(1):90-102, 2018, PMC5752568.
  • Kung TA, Kidwell KM, Speth K, Pang JC, Jagsi R, Levi B, Newman LA, Wilkes EG, Momoh AO; “Radiation-Induced Skin Changes after Post-Mastectomy Radiation Therapy: A Pilot Study on Indicators for Timing of Delayed Breast Reconstruction.”; Journal of Reconstructive Microsurgery. 35(3): 209-215, 2018. 
  • Kurian AW, Bondarenko I, Jagsi R, Friese CR, McLeod CM, Hawley ST, Hamilton AS, Ward KC, Hofer TP, Katz SJ. “Recent Trends in Chemotherapy Use and  Oncologists’ Treatment Recommendations for Early-Stage, Breast Cancer.” J Natl Cancer Inst, 110(5):493-500, 2018, PMC5946952.
  • Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ: “Uptake, Results, and Outcomes of Germline  Multiple-Gene Sequencing After Diagnosis of Breast Cancer.” JAMA Oncol. 4(8)1066-1072, 2018, PMID: 29801090.
  • Lee KL, Janz NK, Zikmund-Fisher BJ, Jagsi R, Wallner LP, Kurian AW, Katz SJ, Abrahamse P, Hawley ST: “What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?” Med Decis Making, 38(1):95-106, 2018, PMC5764769.
  • Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W; “Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.” Cell Metab., 28(1):87-103. 2018.
  • Lin C, Lo M, Moody R, Jiang H, Harouaka R, Stevers N, Tinsley S, Gasparyan M, Wicha M, Sun D, “Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.” Cancer Letters, 438: 165-173. 2018 PMID: 30227220.
  • Linzey J, Bernard M, Pasternak A, Smith C, Miklja Z, Zhao L, Kumar-Sinha C, Paul A, Harris N, Robertson P, Hoffman L, Chinnaiyan, Mody R and Koschmann C. “Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology” (2018). J Neuro-Oncology, 137 (1): 155-169. 2018.
  • Litzenberg DW, Muenz DG, Archer PG, Jackson WC, Hamstra DA, Hearn JW, Schipper MJ, Spratt DE: “Changes in Prostate Orientation Due to Removal of a Foley Catheter.” Med Phys, 45(4):1369-1378, 2018, PMID: 29474748.
  • Ludwig ML, Kulkarni A, Birkeland AC, Michmerhuizen NL, Foltin SK, Mann JE, Hoesli RC, Devenport SN, Jewell BM, Shuman AG, Spector ME, Carey TE, Jiang H, Brenner JC, “The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.” Oral Oncology, 87: 144-151. 2018. PMCID: PMC6349383.
  • Ma VT, Boonstra PS, Menghrajani K, Perkins C, Gowin KL, Mesa RA, Gotlib JR, and Talpaz, M;  “Treatment with JAK inhibitors in myelofibrosis patients nullifies the prognostic impact of unfavorable cytogenetics.” Clinical Lymphoma, Myeloma, and Leukemia 18, e201–e210. 2018. PMC 5927833.
  • Marcath LA, Kidwell KM, Robinson A, Feng L, Vangipuram K, Schott AF, Pai MP, Hayes DF, Henry NL, Hertz DL; “Patients Carrying Low-activity CYP2C8 Genotypes have Shorter Systemic Paclitaxel Exposure.” Pharmacogenomics. 20(2): 95-104, 2018.
  • Marcath LA, Xi J, Hoylman EK, Kidwell KM, Kraft SL, Hertz DL; “Comparison of nine tools for screening drug-drug interactions of Oral Oncolytics” Journal of Oncology Practice. 14(6): 368-374, 2018.
  • McCulloch MM, Muenz DG, Schipper MJ, Velec M, Dawson LA, Brock KK: “A simulation study to assess the potential impact of developing normal tissue complication probability models with accumulated dose.” Adv Radiat Oncol 3(4): 662-672, PMC6200914. 2018.
  • McMullen ER, Gonzalez ME, Skala SL, Tran M, Thomas D, Djomehri SI, Burman B, Kidwell KM, Kleer CG; “CCN6 regulates IGF2BP2 and HMGA2 signaling in metaplastic carcinomas of the breast.” Breast Cancer Research and Treatment. 172(3): 577-586, 2018.
  • Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino C, Cuneo KC, Lawrence TS, Owen D: “MR Imaging Evaluation of Hepatocellular Carcinoma Treated with Stereotactic Body Radiation Therapy (SBRT): Long Term Imaging Follow-Up.” Int J Radiat Oncol Biol Phys: 2018. PM30213751.
  • Mikell JK, Kaza RK, Roberson PL, Younge KC, Srinivasa RN, Majdalany BS, Cuneo KC, Owen D, Devasia T, Schipper MJ, Dewaraja YK: Impact of Y PET gradient-based tumor segmentation on voxel- 90 level dosimetry in liver radioembolization. EJNMMI Phys 5(1): 31, 2018. PM30498973/PMC6265358.
  • Miller M, Trickey A, Kin C, Hawley S, Abrahamse P, Morris A, “Coordination of Care in Colorectal Cancer Patients: A Population-Based Study.”  Journal of the American College of Surgeons, 227(4)S141-S142. 2018.
  • Morrow M, Abrahamse P, Katz SJ: “Trend Analysis on Reoperation After Lumpectomy for Breast Cancer-Reply.” JAMA Oncol, 4(5):747, 2018, PMID: 29423506.
  • Morrow M, Jagsi R, McLeod M, Shumway D, Katz S. “Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer: Has ACOSOG Z0011 Changed Clinical Practice?” JAMA Oncol, 2018. PMC6248076.
  • Muller KE, Zhao L, Jorns JM; “Isolated Atypical Lobular Hyperplasia Diagnosed on Breast Biopsy: Low Upgrade Rate on Subsequent Excision with Long-Term Followup.” Archives of Pathology and Laboratory Medicine, 142(3):391-395. 2018.
  • Muenz D, Braun T, Taylor JMG; “Modeling adverse event counts in phase I clinical trials of a cytotoxic agent”. Clin Trials, 15(4): 386-397, 2018, PMC6053332.
  • Skala SL, Arps DP, Zhao L, Cha KB, Wang M, Harms PW, Andea AA, Fullen DR, Chan MP; “Comprehensive histopathological comparison of epidermotropic/dermal metastatic melanoma and primary nodular melanoma.” Histopathology, 72(3):472-480. 2018.
  • Owen DR, Boonstra PS , Viglianti B, Balter J, Schipper MJ, Jackson W, El Naqa I, Jolly S, Ten Haken RK, and Matuszak MM  “Modeling patient-specific dose-function response using SPECT/CT to personalize prediction of radiation-induced lung toxicity.” International Journal of Radiation Oncology · Biology · Physics 102, 1265–1275; https://doi.org/10.1016/j.ijrobp.2018.05.049, 2018. PMC6202237
  • Owen DR, Boonstra PS, Viglianti BL, Balter JM, Schipper MJ, Jackson WC, El Naqa I, Jolly S, Ten Haken RK, Kong FS, Matuszak MM: “Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage”. Int J Radiat Oncol Biol Phys 102(4): 1265-1275, 2018. PM30108006/PMC6202237.
  • Qin T, Zhang Y, Zarins KR, Jones T, Virani S, Peterson LA, McHugh JB, Chepeha D,Wolf GT, Laura S Rozek LS, Sartor MA: “Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort.” Sci Rep, 8(1):11458, 2018, PMID: 30061624.
  • Resnicow K, Patel M, McLeod M, Katz S, Jagsi R. “Physician Attitudes About Cost Consciousness for Breast Cancer Treatment: Differences by Cancer Sub-specialty.” Breast Cancer Res Treat, 2018. PMID: 30259283.
  • Ropa J, Saha N, Chen Z, Serio J, Chen W, Mellacheruvu D, Zhao L, Basrur V, Nesvizhskii AI and Muntean AG; “PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia.” Oncotarget, 9(31):22123-22136. 2018.
  • Rosko AJ, Birkeland AC, Bellile E, Kovatch KJ, Miller AL, Jaffe CC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME: “Hypothyroidism and Wound Healing After Salvage Laryngectomy.” Ann Surg Oncol, 25(5):1288-1295, PMC6002868.
  • Sapir E, Tao Y, Schipper MJ, Bazzi L, Novelli PM, Devlin P, Owen D, Cuneo KC, Lawrence TS, Parikh ND, Feng M.: “Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.” Int J Rad Oncol Biol Phys, 100(1):122-130, 2018, PMC5818982
  • Schmitd LB, Beesley LJ, Russo N, Bellile EL, Inglehart RC, Liu M, Romanowicz G, Wolf GT, Taylor JMG, D'Silva NJ: “Redefining Perineural Invasion: Integration of Biology With Clinical Outcome.” Neoplasia, 22;20(7):657-667, 2018, PMID: 29800815.
  • Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Mukherjee B: “Novel common genetic susceptibility loci for colorectal cancer” JNCI: Journal of the National Cancer Institute, 111 (2), 146-157. 2018.
  • Schofield HK, Zeller J, Espinoza C, Halbrook CJ, Del Vecchio A, Magnuson B, Fabo T, Daylan AEC, Kovalenko I, Lee HJ, Yan W, Feng Y, Karim SA, Kremer DM, Kumar-Sinha C, Lyssiotis CA, Ljungman M, Morton JP, Galbán S, Fearon ER, Pasca di Magliano M: “Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma.” JCI Insight, 25;3(2). pii: 97422, 2018, PMC5821189.
  • Sehrawat A, Gao L, Wang Y, Bankhead A 3rd, McWeeney SK, King CJ, Schwartzman J, Urrutia J, Bisson WH, Coleman DJ, Joshi SK, Kim DH, Sampson DA, Weinmann S, Kallakury BVS, Berry DL, Haque R, Van Den Eeden SK, Sharma S, Bearss J, Beer TM, Thomas GV, Heiser LM, Alumkal JJ: “LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.” Proc Natl Sci USA, 115(18):E4179-E4188, 2018, PMC5939079.
  • Shankar PR, Kaza RK, Al-Hawary MM, Masch WR, Curci NE, Mendiratta-Lala M, Sakala MD, Johnson TD, Davenport MS. “Impact of Clinical History on Maximum PI-RADS Version 2 Score: A Six-Reader 120-Case Sham History Retrospective Evaluation.” Radiology, 2018, PMID: 29664338.
  • Shergalis A, Bankhead A 3rd, Luesakul U, Muangsin N, Neamati N: “Current Challenges and Opportunities in Treating Glioblastoma.” Pharmacol Rev, 70(3):412-445, 2018, PMC5907910.
  • Shi J, Wang X, Lyu L, Jiang H, Zhu HJ: “Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes.” Drug Metab Pharmacokinet, 33(2):133-140, 2018, PMID: 29610054.
  • Shumway DA, Griffith KA, Hawley ST, Katz SJ, Jagsi R: “Patient Views and Correlates of Radiotherapy Omission in a Population-Based Sample of Older Women with Favorable Prognosis Breast Cancer.” Cancer, 124(13):2714-2723, 2018, PMID: 29669187.
  • Spratt DE, Suresh K, Osawa T, Schipper M, Jackson WC, Abugharib A, Lebastchi A, Smith D, Montgomery JS, Palapattu GS, Priya Kunju L, Wu A, Lew M, Tomlins SA, Chinnaiyan AM, Weizer AZ, Hafez KS, Kaffenberger SD, Udager A, Mehra R: “Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.” Med Oncol, 5(3):21, 2018, PMID: 29387987.
  • Sun Y, Hawkins PG, Bi N, Tewari M, Hearn JWD, Hayman JA, Kalemkerian GP, Lawrence TS, Ten-Haken RK, Matuszak MM, Kong FM, Jolly S, Schipper MJ: “Serum MicroRNA Signature Predicts Response to High-dose Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer.”  Int J Radiat Oncol Biol Phys, 100(1):107-114, 2018, PMC5736451.
  • Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Jackson W, Bazzi L, Ten Haken RK, Lawrence TS, Cuneo K, Feng M, Schipper MJ: “Using Indocyanine Green to Predict Liver Toxicity After Stereotactic Body Radiotherapy for Primary Hepatocellular Carcinoma.” Int J Rad Oncol Biol Phys, 100(1):131-137, 2018, PMC5736416.
  • Svoboda LK, Teh SSK, Sud S, Kerk S, Zebolsky A, Treichel S, Thomas D, Halbrook CJ, Lee HJ, Kremer D, Zhang L, Klossowski S, Bankhead AR, Magnuson B, Ljungman M, Cierpicki T, Grembecka J, Lyssiotis CA, Lawlor ER: “Menin regulates the serine biosynthetic pathway in Ewing sarcoma.” J Pathol, 245(3):324-336, 2018, PMID: 29672864.
  • Tamura S, Wang Y, Veeneman B, Hovelson D, Bankhead A 3rd, Broses LJ, Lorenzatti Hiles G, Liebert M, Rubin JR, Day KC, Hussain M, Neamati N, Tomlins S, Palmbos PL, Grivas P, Day ML: “Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.” Bladder Cancer, 2018 Jan 20;4(1):77-90, 2018, PMC5798519.
  • Tran Q, Kidwell KM, Tsodikov A: “A joint model of cancer incidence, metastasis, and mortality” Lifetime Data Anal, 24(3):385-406, 2018, PMID 28871363.
  • Veenstra CM, Abrahamse P, Wagner TH, Hawley ST, Banerjee M, Morris AM: “Employment benefits and job retention: evidence among patients with colorectal cancer.” Cancer Med, 7(3):736-745, 2018, PMC5852372.
  • Viglianti BL, Wale DJ, Wong KK, Johnson TD, Ky C, Frey KA, Gross MD. “Effects of Tumor Burden on Reference Tissue Standardized Uptake for PET Imaging.” Radiology, 2018, PMID: 29558296.
  • Wages N and Braun T.  “Accuracy, Safety, and Reliability of Novel Phase I Designs – Letter”.  Clinical Cancer Research (24): 5482-5482, 2018. PMID: 29661774.
  • Wahl DR, Kim MM, Aryal MP, Hartman H, Lawrence TS, Schipper MJ, Parmar HA, Cao Y: “Combining Perfusion and High B-value Diffusion MRI to Inform Prognosis and Predict Failure Patterns in Glioblastoma.” Int J Radiat Oncol Biol Phys 102(4): 757-764, 2018. PM29980414.
  • Wang Q, Yan R, Pinnell N, McCarter A C, Oh Y, Liu Y, Sha C, Garber N. F, Chen Y, Wu Q, Ku C J, Tran I, Serna Alarcon A, Kuick R, Engel J D, Maillard I, Cierpicki T, Chiang M Y  “Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development” Blood Journal, 132(12(): 1279-1292. 2018 PMC6148450.
  • Wilson MJ, Sen A, Bridges D, Turgeon DK, Brenner DE, Smith WL, Ruffin MT 4th, Djuric Z; “Higher baseline expression of the PTGS2 gene and greater decreases in total colonic fatty acid content predict greater decreases in colonic prostaglandin-E2 concentrations after dietary supplementation with ω-3 fatty acids”Prostaglandins Leukot Essent Fatty Acids. 2018 Dec;139:14-19. doi: 10.1016/j.plefa.2018.11.001. Epub, 2018. PMID: 30471768
  • Zhang Y,Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y1, Xiao L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish M, Shukla GC, Paulsen MT, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp CS, Freier SM, Watt AT, Guo S, Wei JT, Feng FY, Malik R, Chinnaiyan AM: “Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.” Nat Genet, 50(6):814-824, 2018, PMC5980762.
  • Zhao L, Wu W, Feng D, Jiang H, Nguyen X: “Bayesian Analysis of RNA-seq Data Using a Family of Negative Binomial Models.” Bayesian Anal, 13(2)411-436, 2018.